Skill rankings
Leaderboard
Politicians ranked by disclosed trading activity. Sort by volume (always available), estimated return (where price data exists), or raw trade count.
27,144 trades·$2.2B disclosed·588 politicians·Updated 3h ago
Est. gain/loss and Est. return are estimates — politicians only disclose dollar ranges, not exact share counts, so the numbers are directional, not exact. Skill ranks them by dollar gains weighted by how much they traded (so big wins at scale beat small lucky bets). Not investment advice — every number here comes from public government filings.
Skill scale★★★★★ Elite★★★★ Strong★★★ Solid★★ Mixed★ Weak☆ Loss
Kathy Manning
DHouseNorth Carolina-06
Strong
Net profit
+$3.1M
Est. return
+65.0%
vs S&P 500
+7.9%
Total traded
$9.7M
370/240
Top:
AbbVie
Emily Randall
DHouseWashington-06
U.S. Representative (D) for Washington, 41 years old.
Net profit
—
Est. return
—
vs S&P 500
—
Total traded
$88K
0/11
Top:
Amgen
Dean Phillips
—HouseMinnesota-03
Net profit
—
Est. return
—
vs S&P 500
—
Total traded
$123.5K
0/3
Top:
AstraZeneca
Nicholas V. Taylor
—HouseTexas-03
Net profit
—
Est. return
—
vs S&P 500
—
Total traded
$6.8M
0/7
Top:
Eli Lilly
| # | Politician | Top stock | Total traded | Buys / Sells | Est. gain/loss | Est. return | vs S&P 500 | Skill |
|---|---|---|---|---|---|---|---|---|
Kathy Manning DHouseNorth Carolina-06 | AbbVie ABBV·Pharmaceutical | $9.7M | 370/240 | +$3.1M | +65.0% | +7.9% | Strong | |
Emily Randall DHouseWashington-06 | Amgen AMGN·Pharmaceutical | $88K | 0/11 | — | — | — | — | |
Dean Phillips —HouseMinnesota-03 | AstraZeneca AZN·Pharmaceutical | $123.5K | 0/3 | — | — | — | — | |
Nicholas V. Taylor —HouseTexas-03 | Eli Lilly LLY·Pharmaceutical | $6.8M | 0/7 | — | — | — | — |
How is this ranked? See methodology →Updated 197 min ago